Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
115 hedge funds and large institutions have $528M invested in Intersect ENT, Inc in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 27 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 39
2% more capital invested
Capital invested by funds: $518M → $528M (+$9.49M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $1.13M
8% less funds holding
Funds holding: 125 → 115 (-10)
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$37.6M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.6M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$12M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$10.7M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$25.3M |
| 2 |
State Street
Boston,
Massachusetts
|
-$11.2M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$10.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$7.23M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
-$6.72M |
XENT Hedge Fund Activity: Q4 2015 in Review
115 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2015, worth a combined $528M — up 1.8% from $518M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of XENT and 17 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 44 added.
The largest buyer was Wellington Management Group, adding an estimated $37.6M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $25.3M sold.
- 115 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2015, down from 125 in Q3 2015.
- Funds reported $528M of Intersect ENT, Inc stock for Q4 2015, up 1.8% quarter-over-quarter.
- 17 funds opened new Intersect ENT, Inc positions in Q4 2015 and 27 closed out, a net change of -10 holders.
- The largest Intersect ENT, Inc buyer in Q4 2015 was Wellington Management Group, an estimated $37.6M added.
- The largest Intersect ENT, Inc seller in Q4 2015 was Lord, Abbett & Co, an estimated $25.3M sold.
Based on aggregated 13F filings for Q4 2015.